What is CalciMedica, Inc. Common Stock (CALC) stock price today?

CalciMedica, Inc. Common Stock (CALC) currently trades at $0.62 per share. The stock has a market capitalization of $9.22M and a P/E ratio of —x.

Is CALC stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, CalciMedica, Inc. Common Stock has a Smart Value Score of 19/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is 2/9 and Altman Z-Score is -12.59.

Is CalciMedica, Inc. Common Stock financially healthy?

CalciMedica, Inc. Common Stock's Piotroski F-Score is 2/9 (weak financial health). The Altman Z-Score of -12.59 places it in the distress.

CALC

CalciMedica, Inc. Common Stock

NASDAQ: CALC · HEALTHCARE · BIOTECHNOLOGY

$0.62

+3.47% today

Updated 2026-05-06

Market cap

$9.22M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-1.98

Dividend yield

—

52W range

$0 – $7

Volume

0.3M

Market cap

$9.22M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-1.98

Dividend yield

—

52W range

$0 – $7

Volume

0.3M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

6.5

Quality

3.0

Profitability

5.0

Valuation

C+

2/9

Piotroski F-Score

Weak

-12.6

Altman Z-Score

Distress

—

Industry rank

—

View all highly rated stocks (75+) →197 stocks currently score above 75

Price targets

Analyst target

$10.33

+1559.70%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

Price chart

Stock snapshot

Strengths

+ Debt/equity -33.21x — low leverage

Risks

- Piotroski 2/9 — weak financial health

- Altman Z -12.59 — distress zone

- Thin margins at 0.00%

- Negative free cash flow $-4.86M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$0.00	$0.00	$0.00	$0.00	$0.00
Net income	$-7.82M	$-34.36M	$-13.70M	$-29.56M	$-10.76M
EPS	—	—	—	—	$-1.98
Free cash flow	$-11.76M	$-25.81M	$-21.15M	$-21.21M	$-4.86M
Profit margin	—	—	—	—	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
CALC	$9.22M	19	4.3	3.0	5.0	6.5	—	Avoid
LLY	$862.01B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$546.90B	59	4.7	9.0	3.3	6.0	-40.34%	Buy
ABBV	$365.43B	63	4.0	8.0	4.0	5.0	-22.55%	Buy
UNH	$336.72B	54	5.3	5.5	7.3	4.8	+43.12%	Buy
AZN	$287.11B	64	6.7	8.0	5.3	5.0	+3.99%	Buy

Smart narrative

CalciMedica, Inc. Common Stock trades at $0.62. Our Smart Value Score of 19/100 indicates the stock is weak. The company scores 2/9 on the Piotroski F-Score. With an Altman Z-Score of -12.59, it sits in the distress.

Frequently asked questions

What is CalciMedica, Inc. Common Stock's stock price?

CalciMedica, Inc. Common Stock (CALC) trades at $0.62.

Is CalciMedica, Inc. Common Stock overvalued?

Smart Value Score 19/100 (Grade F, Strong Sell).

What is the price target of CalciMedica, Inc. Common Stock (CALC)?

The analyst target price is $10.33, representing +1559.7% upside from the current price of $0.62.

Piotroski F-Score?

2/9 — weak financial health.

Altman Z-Score?

-12.59 — distress.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio—

ROE-761.00%

Beta1.03

50D MA$0.63

200D MA$2.75

Shares out0.02B

Float0.01B

Short ratio—

Avg volume0.3M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

CALC vs LLY →CALC vs JNJ →CALC vs ABBV →Stock screener →